Price $3.61 |
Market Cap
6.85B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
6.82
|
P/S
1.62
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-145K
|
FCF
-0.3
|
|
Op. Margin
-3.90%
|
Net Margin
-2.40%
|
ROE
-9.10%
|
ROI
-11.80%
|
|
ROA
-4.20%
|
EPS Growth
18.40%
|
Current Ratio
2.7
|
Debt/Equity
3.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $3.09 | - | - | 16.4M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $11.55 | - | - | 78M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
